Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
La Revue Du Praticien
|
October 19, 2019
[Insurability and history of cancer]
Philippe-Jean Bousquet, Lionel Lafay
La Revue Du Praticien
|
February 8, 2024
[After cancer: after-eff ects, return to work and the right to forget]
Jérôme Foucaud, Philippe-Jean Bousquet
The Journal of Allergy and Clinical Immunology
|
March 9, 2005
Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole
Christophe Fontaine, Philippe Jean Bousquet, Pascal Demoly
Current Opinion in Allergy and Clinical Immunology
|
August 14, 2010
Update in drug allergy: novel drugs with novel reaction patterns
Marta Rubio, Philippe-Jean Bousquet, Pascal Demoly
La Revue Du Praticien
|
April 16, 2019
[Incidence, mortality and prevalence of cancers in metropolitan France]
Delphine Lefeuvre, Philippe-Jean Bousquet, Lionel Lafay
La Revue Du Praticien
|
February 8, 2024
[Cancers in France: 10 key messages]
Norbert Ifrah, Jean-Baptiste Méric, Philippe-Jean Bousquet
Applied Health Economics and Health Policy
|
February 15, 2020
Economic Evaluations of Anticancer Drugs Based on Medico-Administrative Databases: A Systematic Literature Review
Elsa Bouée-Benhamiche, Philippe Jean Bousquet, Salah Ghabri
La Revue Du Praticien
|
February 8, 2024
[Cancers: incidence and survival in metropolitan France]
Camille De Brauer, Philippe-Jean Bousquet, Lionel Lafay
International Archives of Allergy and Immunology
|
June 29, 2012
How can we better classify NSAID hypersensitivity reactions?--validation from a large database
Silvia Caimmi, Davide Caimmi, Philippe-Jean Bousquet, et al.
International Archives of Allergy and Immunology
|
July 2, 2011
Patients' satisfaction with diagnostic drug provocation tests and perception of its usefulness
Eva R Gomes, Violeta Kvedariene, Pascal Demoly, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
La Revue Du Praticien
|
October 19, 2019
[Insurability and history of cancer]
Philippe-Jean Bousquet, Lionel Lafay
La Revue Du Praticien
|
February 8, 2024
[After cancer: after-eff ects, return to work and the right to forget]
Jérôme Foucaud, Philippe-Jean Bousquet
The Journal of Allergy and Clinical Immunology
|
March 9, 2005
Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole
Christophe Fontaine, Philippe Jean Bousquet, Pascal Demoly
Current Opinion in Allergy and Clinical Immunology
|
August 14, 2010
Update in drug allergy: novel drugs with novel reaction patterns
Marta Rubio, Philippe-Jean Bousquet, Pascal Demoly
La Revue Du Praticien
|
April 16, 2019
[Incidence, mortality and prevalence of cancers in metropolitan France]
Delphine Lefeuvre, Philippe-Jean Bousquet, Lionel Lafay
La Revue Du Praticien
|
February 8, 2024
[Cancers in France: 10 key messages]
Norbert Ifrah, Jean-Baptiste Méric, Philippe-Jean Bousquet
Applied Health Economics and Health Policy
|
February 15, 2020
Economic Evaluations of Anticancer Drugs Based on Medico-Administrative Databases: A Systematic Literature Review
Elsa Bouée-Benhamiche, Philippe Jean Bousquet, Salah Ghabri
La Revue Du Praticien
|
February 8, 2024
[Cancers: incidence and survival in metropolitan France]
Camille De Brauer, Philippe-Jean Bousquet, Lionel Lafay
International Archives of Allergy and Immunology
|
June 29, 2012
How can we better classify NSAID hypersensitivity reactions?--validation from a large database
Silvia Caimmi, Davide Caimmi, Philippe-Jean Bousquet, et al.
International Archives of Allergy and Immunology
|
July 2, 2011
Patients' satisfaction with diagnostic drug provocation tests and perception of its usefulness
Eva R Gomes, Violeta Kvedariene, Pascal Demoly, et al.
Page
of 7